Companies / Croatia
Drug Market Expands
January 2007 | Industry ForecastTo the benefit of vaccine manufacturers and drugmakers, Croatia has made vaccination against the hepatitis B virus compulsory for children and simultaneously quadrupled its budget for "expensive" drugs in 2007. Accordingly, BMI has slightly increased its forecast for the country's pharmaceutical market. We now expect the value of the market to reach US$720mn in 2010, up from US$670mn
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.



